Patents Assigned to LONGUIDE BIOPHARMA CORPORATION
  • Lipids and lipid nanoparticle formulations
    Patent number: 12233161
    Abstract: The present disclosure relates generally to lipids, lipid nanoparticle formulations, and methods of using the same for delivering nucleic acids, such as mRNA.
    Type: Grant
    Filed: May 20, 2024
    Date of Patent: February 25, 2025
    Assignee: LONGUIDE BIOPHARMA CORPORATION
    Inventors: Longgui Zhang, Yuebao Zhang, Chen Liu, Xiuting Xu, Yan Wang, Meigui Liang, Yuanyuan Xu, Wenting Song, Zehao Liao, Qinying Zhu, Yingxin Lu